Phenazopyridine Hydrochloride
Last Updated: March 8, 2017
Status: Current
Products Affected - Description
Phenazopyridine oral tablet, Marlex
100 mg tablets, 6 count (NDC 10135-0199-78) - discontinued
100 mg tablets, 30 count (NDC 10135-0199-30) - discontinued
100 mg tablets, 1000 count (NDC 10135-0199-01) - discontinued
100 mg tablets, 1000 count (NDC 10135-0199-10) - discontinued
Reason for the Shortage
- Amneal Pharmaceuticals, Avkare, SDA Laboratories discontinued phenazopyridine tablets.
- Gemini Laboratories has new NDC numbers for Pyridium products. Gemini has product available.
- Marlex has new NDC numbers for the generic phenazopyridine 100 mg and 200 mg tablets. These are available.
Available Products
Pyridium oral tablet, Gemini Laboratories
100 mg, 100 count (NDC 60846-0501-01)
200 mg, 100 count (NDC 60846-0502-01)
Phenazopyridine oral tablet, Marlex
100 mg, 100 count (NDC 10135-0620-01)
100 mg, 100 count (NDC 10135-0620-01)
200 mg, 100 count (NDC 10135-0621-01)
Estimated Resupply Dates
- Marlex has phenazopyridine 100 mg and 200 mg tablets available.
- Gemini Laboratories has Pyridium 100 mg and 200 mg tablets available.
Related Shortages
- Dibucaine Ointment — Resolved
Updated
August 6, July 19, May 13, February 10, 2016; December 9, September 10, July 1, June 30, May 20, April 8, February 11, 2015; December 10, November 20, 2014, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.
